Remove 2026 Remove Documentation Remove Dosage
article thumbnail

Can holograms help in the frontline fight against pharmaceutical counterfeiting?

European Pharmaceutical Review

With predictions that the global market for anticounterfeiting packaging is set to reach almost $250 billion by 2026, growth in authentication and anti-tamper devices such as holograms appear to have a healthy future.” Blister packs can also benefit from anticounterfeiting holography.

Packaging 111
article thumbnail

Apixaban vs warfarin: rise of newer anticoagulant

Druggist

Eliquis is still protected by patent rights in the UK, with exclusive availability rights until 2026 (IPO, 2021). . Additionally, the dosage is much simpler as compared to warfarin as it does not change generally after treatment initiation is completed. . In the UK, apixaban is known as a branded drug called Eliquis®.

article thumbnail

FDA’s Proposal to Remove Oral Phenylephrine from the OTC Monograph Isn’t a Surprise but What is Left “Over-the-Counter”?

The FDA Law Blog

That means almost certainly no sooner than the second half of 2026. As dictated by the process provided for in the 2020 CARES Act, FDA announced issuance of the proposed order in a Federal Register notice and published the proposed order itself on FDA’s website.

FDA 111